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ABSTRACT 
Background 
Pain is often experienced by patients with functional dystonia and idiopathic cervical 
dystonia and it is likely to be underlined by different neural mechanisms.  
Objective 
In this exploratory study, we tested the sensory-discriminative and cognitive-emotional 
component of pain in patients with functional and idiopathic dystonia.  
Methods 
Ten patients with idiopathic cervical dystonia, 12 patients with functional dystonia and 16 
age- and gender matched healthy controls underwent psychophysical testing of tactile and 
pain thresholds and pain tolerance. We delivered electrical pulses of increasing intensity to 
the index finger of each hand and the halluces of each foot. Pain threshold and Pain 
tolerance were respectively defined as: 1) the intensity at which sensation changed from 
unpainful to faintly painfull and 2) the intensity at which painful sensation was intolerable.  
Results 
No differences were found between the three groups for tactile and pain thresholds 
assessed in both hands and feet. Pain tolerance was significantly increased in all body 
district only in functional dystonia. Patients with continuous functional dystonia had higher 
pain tolerance compared to subjects with paroxysmal functional dystonia and idiopathic 
cervical dystonia. Spearman Rank Correlation did not demonstrate any correlation 
between pain tolerance and pain scores, depression, anxiety, disease duration and motor 
disability in both groups.  
Conclusions 
Patients with functional dystonia have a dissociation between the sensory-discriminative 
and cognitive-emotional component of pain, as revealed by normal pain thresholds and 
increased pain tolerance. An abnormal connectivity between the motor and the limbic 
system might account for abnormal pain processing in functional dystonia. 
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INTRODUCTION 
Functional neurological disorders (FND) have been recently better defined at 
pathophysiological level and distinguished from symptoms that are intentionally produced, 
such as malingering and factitious disorder1. FND are a source of major neurological 
disability, especially when they produce a motor disturbance, such as in Functional 
Dystonia (F-Dys). Patients affected by F-Dys often experience pain, which is sometimes 
disproportionate to motor symptoms and it frequently occurs in body segments not 
affected by involuntary movements2. Subjects with idiopathic cervical dystonia also 
experience painful sensations, especially in affected body parts3.  
The large brain network accessed during nociceptive processing is now commonly 
referred to as the ‘‘pain matrix’’ and it includes lateral (sensory-discriminatory) and medial 
(affective-cognitive) neuroanatomical components4. The lateral pathway projects to lateral 
thalamus and then to primary and secondary somatosensory areas, while the medial 
pathway projects to medial thalamic nuclei and limbic structures, such as the anterior 
cingulate cortex and the insular cortex. Sensory-discriminative and cognitive-affective 
aspects of pain may be selectively assessed by simple and reliable psycophysical 
parameters, such as the sensory thresholds. In particular, the pain threshold (P-Th) 
evaluates the sensory-discriminative component of pain, whereas the pain tolerance (P-
tol) refers to the psychological perception of pain, a complex balance between cognitive 
and affective functions5. The contribution of the somatosensory system is well-known in 
idiopathic dystonia (including CD)6 and it was recently demonstrated in functional dystonia 
(F-Dys), by testing of tactile temporal discrimination thresholds7. Yet, experimental data on 
pain perception are missing in both F-Dys and idiopathic cervical dystonia, which is often 
associated to pain. Only one study employing laser evoked potentials has revealed that 
the function of nociceptive pathways in cervical dystonia is comparable to healthy 
subjects8.   
Based on the evidence that in F-Dys there is an abnormal connectivity between motor and 
limbic areas9, we hypothesized an alteration of the cognitive-emotional component of pain 
in F-Dys. On the other hand, patients with idiopathic dystonia have an abnormal temporal 
processing of somatosensory stimuli10 and a distorsion of cortical maps in the 
somatosensory cortex11, which might determine an alteration of the sensory-discriminatory 
component of pain. Given these premises, in the present study we aimed to assess the 
sensory-discriminative and cognitive-emotional components of pain in idiopathic cervical 
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dystonia and F-Dys, testing pain thresholds and pain tolerance in affected and unaffected 
body segments.  
METHODS  
We enrolled 10 patients with idiopathic cervical dystonia (CD), 12 patients with clinically 
definite F-Dys12 and 16 healthy controls (HC) (13 females, 3 males; mean age =  
34.6±10.8 years).  
The diagnosis of idiopathic dystonia was based on the Movement Disorders Society 
recommendations13 and the diagnosis of F-Dys on Gupta-Lang criteria12. Exclusion criteria 
were presence of clinically relevant cognitive impairment (MMSE < 24), diabetes mellitus, 
tendon areflexia and polyneuropathy by nerve conduction studies. Severity of dystonia 
was evaluated with the Burke-Fahn-Marsden scale14 in all patients with F-Dys and CD. We 
also employed the Psychogenic Movement Disorders Rating Scale (PMDRS)15  in F-dys. 
In each patient, we retrieved demographical and clinical features (age at onset, disease 
duration, affected body districts).  
Pain was assessed using the pain score of the Toronto Western Spasmodic Torticollis 
Rating Scale (TWSTRS)16. The TWSTRS includes pain scores for severity (0-10), duration 
(0-5) and pain-related disability (0-5). Moreover, all the different painful body segments 
were recorded, including those without dystonia. Depression and anxiety were evaluated 
in patients and controls with Hamilton depression Rating Scale (HAM-D) and Hamilton 
Anxiety Rating Scale (HAM-A). In all patients treated with botulinum toxin (BoNT), the 
experiment was carried out at least 3 months after the injection.  
Tactile and pain thresholds were determined by the method of limits, according to a 
previous published protocol5, 17. The stimulus consisted of a square wave electrical pulse 
of 0.2 ms delivered by a current stimulator (Digitimer D360, Digitimer Ltd, UK) through 
AgCl surface skin ring electrodes. The anode was located 1.5 cm distally from the 
cathode. Hands and feet were tested separately in a random order across patients. 
Electrical stimuli of increasing intensity were delivered to the little finger and big toe of both 
sides. In brief, the lowest intensity of stimulus (0.5 mA) was increased by 0.5 mA steps 
until the subject perceived the electrical stimulus (tactile threshold; T-Th). When the 
subject perceived the electrical stimulus, we delivered decreasing stimuli with minimum 
difference in intensity (0.1 mA) until the correct T-Th was determined. We considered as 
exact T-Th the value to which the subject gave the same affirmative answer after four 
consecutive stimuli at the same intensity. Then, the intensity of electrical stimulus was 
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increased by 0.5 mA steps until the subject reported a change in sensation from unpainful 
to ‘‘faintly painful’’ (pain threshold, P-Th). The patient was asked to point out his pain 
intensity on a Visual Analogue Scale (VAS) line ranging from 0 to 10. Finally, the intensity 
of electrical stimulus was increased by 1 mA steps until the subject reported an 
‘‘intolerable’’ painful sensation (pain tolerance, P-Tol). If the subject did not report an 
intolerable pain sensation with 99 mA at 0.2 ms of stimulus duration, we increased the 
stimulus duration to 0.5 ms and 1 sec (3 subjects with F-Dys described in the results).  
In order to avoid the pain-modulating effects of BoNT injections, the experiments were 
performed with a distance after the last botulinum treatment of at least 3 months. 
The study was approved by the ethic committee of University of Verona and conformed to 
the Declaration of Helsinki. All patients gave their written informed consent prior to 
participation. 
STATISTICAL ANALYSIS  
Normal distribution was checked using the Kolmogorov-Smirnov test. In case of deviation 
from normality, non-parametric tests were used.  
Kruskal-Wallis test was employed to compare HC, F-Dys and CD for age and education 
level. Disease duration in F-Dys and CD was compared using the Mann-Whitney U test.   
Differences in T-Th, P-Th and P-Tol among the 3 groups of subjects were explored by 
repeated measures analysis of variance (R-ANOVA) with “group” as between subjects 
factor (3 levels: HC, F-Dys and CD) and “side” (two levels: right, left) as within-subjects 
factor. The second aim of our study was to understand if pain thresholds were different in 
patients with F-Dys according to the temporal pattern of dystonic symptoms, namely 
patients with persistent versus paroxysmal symptoms. Accordingly, for each 
psychophysical variable (T-Th, P-Th and P-Tol), we run a separate R-ANOVA with “group” 
as between subjects factor (three levels: continuous F-Dys, paroxysmal F-Dys, CD) and 
“side” (two levels: right, left) as within-subjects factor.  
Conditional on a significant F-value, post-hoc unpaired t-tests were performed to 
demonstrate differences between groups in each body site. Correction for multiple 
comparisons was not conducted given the exploratory nature of the study.  
In F-Dys and CD, correlational analysis was performed by Spearman rank-correlation 
using P-tol values averaged between the right and left hand or foot. We verified whether 
P-Tol values were correlated to age, age at onset, disease duration, BFM scale, pain 
scores of TWSTRS (severity, duration, disability due to pain), HAM-D and HAM-A. 
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Significance level was set at p ≤ 0.05. Unless otherwise stated, data are given as mean ± 
standard deviation (SD).   
RESULTS 
Distribution of gender was comparable among the 3 groups (G-squared p-value = 0.6). 
Kruskall-Wallis analysis did not disclose any difference in age (p=0.08), although patients 
with CD were older compared to HC (p=0.01). Age was comparable between HC and F-
dys (p=0.5) and tended to be higher in CD compared to F-Dys (p=0.06). All patients with 
CD and 4 out of 12 patients with F-Dys have been chronically treated with BoNT, 
performed at least 3 months before the experiment. Supplementary table online shows 
details on each patient’s oral medications.  
Tables 1 reports the features of patients with F-Dys and CD.  At the time of the 
assessment, the two groups were comparable for age of onset (F-Dys=27.3±12.1 years, 
CD=37.5±15.8; p= 0.5), disease duration (p=0.7), level of anxiety (p=0.9) and depression 
(p=0.8). Among F-Dys, 4 patients had an exclusive involvement of facial muscles and the 
movement disorder was paroxysmal in 6 patients. The mean PMDRS score was 23.3+2.8. 
CD patients had isolated cervical dystonia, except for two patients who also presented 
writer's cramp. 
The values of S-Th, P-Th and P-Tol in HC, CD, F-Dys recorded from the right and left 
hand and foot are displayed in table 2. For both S-Th and P-Th, R-ANOVA did not show 
any effect of the factor "group".  No effect of group was found for pain intensity at pain 
threshold level by VAS (hands: F2,35=0.56, p=0.57; feet: F2,35=1.31, p=0.29). An effect of 
the factor "group" was found for P-Tol in both the hands (F2,35=3.766, p=0.033) and the 
feet (F2,35=3.986, p= 0.028). No effect of the factor “side” (hands: F2,35=0.68, p= 0.41; feet: 
F2,35=0.16, p= 0.70) nor an interaction “side*group” (hand: F2,35=1.27, p= 0.29; feet: 
F2,35=0.02, p= 0.99) was found. Post-hoc analysis by unpaired t-test revealed a higher P-
Tol in F-Dys compared to HC and CD, in the upper and lower limbs; no differences of P-
Tol were found between CD and HC.   
Figure 1 shows the individual values for P-Th and P-Tol in the 3 groups of subjects. For P-
Tol, we had to increase the stimulus duration in 3 subjects with F-Dys who reported an 
unbearable stimulation at 0.5 ms (2 subjects for the right hand, right foot, left foot; 1 
subject for the left hand) and 1 second (1 subject for all body districts.). As it was not 
possible to account for stimulus duration in the analysis only for 3 subjects, a value of 100 
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mA (corresponding to the maximal allowed stimulation with 0.2 ms pulse width) was set as 
P-Tol in these subjects.  
To understand if the increased P-Tol was influenced by the temporal course of functional 
dystonic manifestation (persistent or paroxysmal), we conducted a further analysis 
comparing CD patients to F-Dys with persistent (continuous F-Dys) and paroxysmal 
(paroxysmal F-Dys) functional symptoms. There was no main effect of the factor "group" 
both for S-Th in hands (F2,19= 1.41, p = 0.27) and feet (F2,19= 2.11, p = 0.16) and P-Th in 
hands (F2,19= 0.82, p = 0.45) and feet (F2,19= 0.99, p = 0.39). Neither a significant effect of 
“side” or an interaction “side*group” were found for S-Th and P-Th in the hands and feet.  
For P-Tol, we found a “group” effect (F2,19=9.89; p=0.001), but neither an effect of “side” 
(F2,19=1.63; p=0.21) nor an interaction “side*group” (F2,19=0.4; p=0.67). This effect was 
determined by a higher P-Tol in both hands and feet of F-Dys with continuous F-Dys 
compared to paroxysmal F-Dys and CD (Figure 2). Similar results for P-Tol were disclosed 
also in the lower limbs, as revealed by a main effect of “group” (F2,19=4.15; p=0.03) but 
neither an effect of “side” (F2,19=0.06; p=0.81) nor an interaction “side*group” (F2,19=0.01; 
p=0.98) (Figure 2).  
In CD and F-Dys, Spearman Rank Correlation did not show any correlation between P-tol 
in hands and feet with age, disease duration, pain scores of the TWSTRS, BFM, HDRS, 
HARS (Table 3). Only HDRS was correlated to pain severity score of the TWSTRS in F-
Dys. 
DISCUSSION 
Painful sensory modalities have been poorly examined in idiopathic cervical dystonia and 
functional dystonia, two conditions characterized by pain, likely to be underlined by a 
different mechanism. Tactile and pain thresholds were comparable between F-Dys, CD 
and HC, whereas pain tolerance was higher in F-Dys. This increase occured in both the 
upper and lower limbs only in subjects with persistent F-Dys, as paroxysmal F-Dys and 
idiopathic cervical dystonia had comparable pain tolerance.  
Pain is a frequent feature associated to cervical dystonia, occurring in up to 88.9% of 
patients naïve to BoNT and being correlated with severity of dystonic symptoms3. Whether 
pain in cervical dystonia is related to chronic muscular contraction or is generated by an 
alteration of transmission and processing of nociceptive stimuli has been matter of debate 
for a long time8, 18-20. Several sensory modalities have been explored in idiopathic isolated 
dystonia and one of the most frequently reported alteration is the prolonged temporal 
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tactile discrimination threshold, which is a common feature to different types of dystonia, 
regardless the affected body segment 21, 22. Pain is a sensory modality, which is 
transmitted by A-δ and C fibers and can be explored using a variety of stimuli, including 
pain thresholds evoked by thermal sensation and mechanical pressure. Electrical 
stimulation at high intensity as per pain threshold testing can stimulate small diameter, 
high threshold cutaneous afferents (A-delta) and even C-fibers23. When considering 
perception of mechanical painful stimuli, two studies on pain-pressure thresholds were 
conducted in CD with opposite results. An earlier study found reduced pain-pressure 
thresholds in 9 patients with CD (6 of them never treated with BoNT) compared to 5 
healthy subjects19. However, when assessing a larger sample of 39 patients with CD, 
Kutvonen and coworkers found normal pain-pressure thresholds20. The normality of pain 
thresholds and tolerance in our CD sample parallels these early findings, obtained with 
pressure painful stimuli and supports the view that at least cutaneous nociceptive 
pathways are normal in patients with idiopathic CD chronically treated with BoNT. Overall, 
they are in keeping with the evidence that the amplitude of N2/P2 at laser evoked potential 
is comparable between CD and healthy subjects, regardless of stimulating a painful or 
painless area in dystonia8.  
The abnormality of pain tolerance only in patients with persistent dystonic functional 
symptoms supports the recent view that there are distinct phenotypes among F-Dys24. 
However, data on pathophysiological differences among F-Dys phenotypes are not 
available. The increase of pain tolerance together with the normality of pain threshold, 
suggests a dissociation between the sensory-discriminative and cognitive-affective 
components of pain in persistent F-Dys. These two dimensions of pain are regulated by 
separate but parallel neural systems, respectively the lateral pain system (sensory-
discriminative dimension of pain) and the medial pain system (cognitive-affective 
dimension of pain)25. The lateral system projects to the primary somatosensory cortex 
through the lateral thalamic nuclei whereas the medial system projects to several brain 
regions, including the cingulate cortex and limbic system, via the medial medial thalamic 
nuclei. The two systems are functionally segregated and can be separately assessed by 
applying nociceptive stimuli of different intensities26. The dissociation of the two systems in 
F-dys is in keeping with two previous studies, reporting increased pain tolerance and 
normal sensory-discriminative thresholds in patients with multisomatoform disorders27, 28. 
The category “somatoform” refers to DSM-IV TR, which included in this entity somatization 
and conversion disorder, pain, hypochondria and body dysmorphic disorder. Clinical 
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features of subjects in these previous reports were not specified, therefore it is not 
possible to ascertain whether any functional movement disorder and more specifically 
functional dystonia was included. Nevertheless, both these studies reported averaged 
values from the right and the left hand and did not assess lower limbs.  
Two psychological features of patients with FND might explain the increased pain 
tolerance in F-Dys: 1) the higher frequency of alexithymia, which refers to the inability to 
identify one’s own emotions at a cognitive level29; 2) the lower interoceptive awareness, 
which is predictive of their tendency to focus on the external features of their body30. A 
similar reduced interoceptive sensitivity was also found in somatoform patients who 
disclosed increased pressure-pain tolerance27.  
A hypothesis to explain our findings in F-Dys is that the increased pain tolerance might be 
caused by abnormalities in limbic areas involved in emotion and pain processing (anterior 
cingulate cortex) and implicated in assigning emotional salience (amygdala, anterior 
insula, and posterior cingulate cortex). Indeed, abnormalities in areas involved in emotion 
recognition and processing has been shown in patients with FND31-33. Moreover, FND 
subjects have reduced activity and lower connectivity of the right temporoparietal junction 
(an area involved in generating an appropriate sensory prediction signal) with 
sensorimotor and limbic regions, such as the anterior cingulate cortex and right ventral 
striatum32. Noteworthy, deep brain stimulation or lesioning of the anterior cingulate cortex 
are able to decrease the affective response to noxious stimuli and are employed to treat 
major depression or intractable pain34. This hypothesis needs confirmation by further 
studies emplying functional neuroimaging with pain stimuli tasks as well ass assessment 
of emotional processing and alexithymia.  
When interpreting our results, we should also consider recent theories on FND35  
postulating that two important mechanisms for generating these abnormal movements are 
self-focus attention and ‘brain-expectations’. In fact, strong "top down” influences, such 
“prior beliefs” would tend to modify any "bottom up" sensory information. Moreover, 
excessive attention towards the body36 might underlie the decrease in externally directed 
attention. These could influence the cognitive appraisal of pain tolerance. However, this 
mechanism would not entirely explain the dissociation between pain threshold and 
tolerance in F-Dys. 
Finally, chronic functional dystonia might have determined a reorganization of sensory 
areas, as it has been demonstrated in complex pain regional syndrome type I, a condition 
that should be included into the functional symptoms spectrum based on clinical and 
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neurophysiological evidence37. When dealing with pain it is also fundamental to discuss 
the role of emotions and mood on pain processing. Indeed, decreased pain thresholds and 
pain tolerances in Parkinson’s disease were correlated to severity of depressive 
symptoms5 and a similar association was found in patients with major depressive 
disorder17.  Regarding the relationship between anxiety and pain tolerance, the literature 
has been controversial on this topic, with reports of decreased pain tolerance in post-
traumatic stress disorder38 or lack of correlation between anxiety and pain tolerance in 
patients with juvenile fibromyalgia38. Accordingly, we screened our sample for depression 
and anxiety and we could not find any correlation with pain tolerance, which also had an 
inverse pattern in F-Dys compared to subjects with major depression. Yet, we need to 
recognize that we did not employ measures of state anxiety and depression that have 
been found to modulate pain perception.   
We recognize that the small sample size of this exploratory study represents an important 
limitation, given the inter-subject variability of psychophysical data, especially in the lower 
limbs. Even though we could not find any correlation between age and pain tolerance in F-
Dys, CD and HC, the role of age on pain tolerance should be specifically addressed in 
future studies, as it has been done for parameters of somatosensory processing, such as 
tactile temporal discrimination thresholds39, 40. Moreover, objective measures such as pain 
evoked potentials or galvanic skin response should be added to P-Tol assessment in 
future studies investigating pain processing in functional dystonia. Chronic treatment with 
botulinum toxin and oral medication might also have interfered with pain thresholds 
testing, although they were equally distributed between patients’ groups.  
In conclusion, we reported a dissociation between the discriminative and affective 
dimension of pain in patients with persisten F-Dys, documented by a marked increase in 
pain tolerance in all body parts. Our data shed a light on the dissociation between pain 
perception and its emotional processing in patients with functional dystonia, which might 
be used to develop novel rehabilitation protocols, given the profound disability caused by 
pain and its negative impact on the selection for current physiotherapy protocols41.  
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LEGEND TO FIGURES 
Figure 1. Individual values for pain threshold and pain tolerance in functional dystonia (F-
Dys) compared to idiopathic cervical dystonia (CD) and healthy controls (HC). CD = 
cervical dystonia; F-Dys= functional dystonia; HC = healthy controls; PT = pain threshold; 
P-Tol = Pain tolerance. Dotted and dashed lines respectively refer to the mean and 
standard deviation across the 3 groups. 
 
Figure 2. Pain tolerance was significantly increased in the both hands of subjects with 
persistent functional dystonia (F-Dys-C) compared to paroxysmal functional dystonia (F-
Dys-P) and cervical dystonia (CD). Pain tolerance was increased in both feet of F-Dys-C 
compared to CD; the difference between F-Dys-C and F-Dys-P did not reach statistical 
significance when considering P-Tol in both feet.  
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ABSTRACT 
Background 
Pain is often experienced by patients with functional dystonia and idiopathic cervical 
dystonia and it is likely to be underlined by different neural mechanisms.  
Objective 
In this exploratory study, we tested the sensory-discriminative and cognitive-emotional 
component of pain in patients with functional and idiopathic dystonia.  
Methods 
Ten patients with idiopathic cervical dystonia, 12 patients with functional dystonia and 16 
age- and gender matched healthy controls underwent psychophysical testing of tactile and 
pain thresholds and pain tolerance. We delivered electrical pulses of increasing intensity to 
the index finger of each hand and the halluces of each foot. Pain threshold and Pain 
tolerance were respectively defined as: 1) the intensity at which sensation changed from 
unpainful to faintly painfull and 2) the intensity at which painful sensation was intolerable.  
Results 
No differences were found between the three groups for tactile and pain thresholds 
assessed in both hands and feet. Pain tolerance was significantly increased in all body 
district only in functional dystonia. Patients with continuous functional dystonia had higher 
pain tolerance compared to subjects with paroxysmal functional dystonia and idiopathic 
cervical dystonia. Spearman Rank Correlation did not demonstrate any correlation 
between pain tolerance and pain scores, depression, anxiety, disease duration and motor 
disability in both groups.  
Conclusions 
Patients with functional dystonia have a dissociation between the sensory-discriminative 
and cognitive-emotional component of pain, as revealed by normal pain thresholds and 
increased pain tolerance. An abnormal connectivity between the motor and the limbic 
system might account for abnormal pain processing in functional dystonia. 
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INTRODUCTION 
Functional neurological disorders (FND) have been recently better defined at 
pathophysiological level and distinguished from symptoms that are intentionally produced, 
such as malingering and factitious disorder1. FND are a source of major neurological 
disability, especially when they produce a motor disturbance, such as in Functional 
Dystonia (F-Dys). Patients affected by F-Dys often experience pain, which is sometimes 
disproportionate to motor symptoms and it frequently occurs in body segments not 
affected by involuntary movements2. Subjects with idiopathic cervical dystonia also 
experience painful sensations, especially in affected body parts3.  
The large brain network accessed during nociceptive processing is now commonly 
referred to as the ‘‘pain matrix’’ and it includes lateral (sensory-discriminatory) and medial 
(affective-cognitive) neuroanatomical components4. The lateral pathway projects to lateral 
thalamus and then to primary and secondary somatosensory areas, while the medial 
pathway projects to medial thalamic nuclei and limbic structures, such as the anterior 
cingulate cortex and the insular cortex. Sensory-discriminative and cognitive-affective 
aspects of pain may be selectively assessed by simple and reliable psycophysical 
parameters, such as the sensory thresholds. In particular, the pain threshold (P-Th) 
evaluates the sensory-discriminative component of pain, whereas the pain tolerance (P-
tol) refers to the psychological perception of pain, a complex balance between cognitive 
and affective functions5. The contribution of the somatosensory system is well-known in 
idiopathic dystonia (including CD)6 and it was recently demonstrated in functional dystonia 
(F-Dys), by testing of tactile temporal discrimination thresholds7. Yet, experimental data on 
pain perception are missing in both F-Dys and idiopathic cervical dystonia, which is often 
associated to pain. Only one study employing laser evoked potentials has revealed that 
the function of nociceptive pathways in cervical dystonia is comparable to healthy 
subjects8.   
Based on the evidence that in F-Dys there is an abnormal connectivity between motor and 
limbic areas9, we hypothesized an alteration of the cognitive-emotional component of pain 
in F-Dys. On the other hand, patients with idiopathic dystonia have an abnormal temporal 
processing of somatosensory stimuli10 and a distorsion of cortical maps in the 
somatosensory cortex11, which might determine an alteration of the sensory-discriminatory 
component of pain. Given these premises, in the present study we aimed to assess the 
sensory-discriminative and cognitive-emotional components of pain in idiopathic cervical 
Page 19 of 38
John Wiley & Sons
Movement Disorders
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Morgante et al, Pain processing in CD and F-Dys 
 
4 
 
dystonia and F-Dys, testing pain thresholds and pain tolerance in affected and unaffected 
body segments.  
METHODS  
We enrolled 10 patients with idiopathic cervical dystonia (CD), 12 patients with clinically 
definite F-Dys12 and 16 healthy controls (HC) (13 females, 3 males; mean age =  
34.6±10.8 years).  
The diagnosis of idiopathic dystonia was based on the Movement Disorders Society 
recommendations13 and the diagnosis of F-Dys on Gupta-Lang criteria12. Exclusion criteria 
were presence of clinically relevant cognitive impairment (MMSE < 24), diabetes mellitus, 
tendon areflexia and polyneuropathy by nerve conduction studies. Severity of dystonia 
was evaluated with the Burke-Fahn-Marsden scale14 in all patients with F-Dys and CD. We 
also employed the Psychogenic Movement Disorders Rating Scale (PMDRS)15  in F-dys. 
In each patient, we retrieved demographical and clinical features (age at onset, disease 
duration, affected body districts).  
Pain was assessed using the pain score of the Toronto Western Spasmodic Torticollis 
Rating Scale (TWSTRS)16. The TWSTRS includes pain scores for severity (0-10), duration 
(0-5) and pain-related disability (0-5). Moreover, all the different painful body segments 
were recorded, including those without dystonia. Depression and anxiety were evaluated 
in patients and controls with Hamilton depression Rating Scale (HAM-D) and Hamilton 
Anxiety Rating Scale (HAM-A). In all patients treated with botulinum toxin (BoNT), the 
experiment was carried out at least 3 months after the injection.  
Tactile and pain thresholds were determined by the method of limits, according to a 
previous published protocol5, 17. The stimulus consisted of a square wave electrical pulse 
of 0.2 ms delivered by a current stimulator (Digitimer D360, Digitimer Ltd, UK) through 
AgCl surface skin ring electrodes. The anode was located 1.5 cm distally from the 
cathode. Hands and feet were tested separately in a random order across patients. 
Electrical stimuli of increasing intensity were delivered to the little finger and big toe of both 
sides. In brief, the lowest intensity of stimulus (0.5 mA) was increased by 0.5 mA steps 
until the subject perceived the electrical stimulus (tactile threshold; T-Th). When the 
subject perceived the electrical stimulus, we delivered decreasing stimuli with minimum 
difference in intensity (0.1 mA) until the correct T-Th was determined. We considered as 
exact T-Th the value to which the subject gave the same affirmative answer after four 
consecutive stimuli at the same intensity. Then, the intensity of electrical stimulus was 
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increased by 0.5 mA steps until the subject reported a change in sensation from unpainful 
to ‘‘faintly painful’’ (pain threshold, P-Th). The patient was asked to point out his pain 
intensity on a Visual Analogue Scale (VAS) line ranging from 0 to 10. Finally, the intensity 
of electrical stimulus was increased by 1 mA steps until the subject reported an 
‘‘intolerable’’ painful sensation (pain tolerance, P-Tol). If the subject did not report an 
intolerable pain sensation with 99 mA at 0.2 ms of stimulus duration, we increased the 
stimulus duration to 0.5 ms and 1 sec (3 subjects with F-Dys described in the results).  
In order to avoid the pain-modulating effects of BoNT injections, the experiments were 
performed with a distance after the last botulinum treatment of at least 3 months. 
The study was approved by the ethic committee of University of Verona and conformed to 
the Declaration of Helsinki. All patients gave their written informed consent prior to 
participation. 
STATISTICAL ANALYSIS  
Normal distribution was checked using the Kolmogorov-Smirnov test. In case of deviation 
from normality, non-parametric tests were used.  
Kruskal-Wallis test was employed to compare HC, F-Dys and CD for age and education 
level. Disease duration in F-Dys and CD was compared using the Mann-Whitney U test.   
Differences in T-Th, P-Th and P-Tol among the 3 groups of subjects were explored by 
repeated measures analysis of variance (R-ANOVA) with “group” as between subjects 
factor (3 levels: HC, F-Dys and CD) and “side” (two levels: right, left) as within-subjects 
factor. The second aim of our study was to understand if pain thresholds were different in 
patients with F-Dys according to the temporal pattern of dystonic symptoms, namely 
patients with persistent versus paroxysmal symptoms. Accordingly, for each 
psychophysical variable (T-Th, P-Th and P-Tol), we run a separate R-ANOVA with “group” 
as between subjects factor (three levels: continuous F-Dys, paroxysmal F-Dys, CD) and 
“side” (two levels: right, left) as within-subjects factor.  
Conditional on a significant F-value, post-hoc unpaired t-tests were performed to 
demonstrate differences between groups in each body site. Correction for multiple 
comparisons was not conducted given the exploratory nature of the study.  
In F-Dys and CD, correlational analysis was performed by Spearman rank-correlation 
using P-tol values averaged between the right and left hand or foot. We verified whether 
P-Tol values were correlated to age, age at onset, disease duration, BFM scale, pain 
scores of TWSTRS (severity, duration, disability due to pain), HAM-D and HAM-A. 
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Significance level was set at p ≤ 0.05. Unless otherwise stated, data are given as mean ± 
standard deviation (SD).   
RESULTS 
Distribution of gender was comparable among the 3 groups (G-squared p-value = 0.6). 
Kruskall-Wallis analysis did not disclose any difference in age (p=0.08), although patients 
with CD were older compared to HC (p=0.01). Age was comparable between HC and F-
dys (p=0.5) and tended to be higher in CD compared to F-Dys (p=0.06). All patients with 
CD and 4 out of 12 patients with F-Dys have been chronically treated with BoNT, 
performed at least 3 months before the experiment. Supplementary table online shows 
details on each patient’s oral medications.  
Tables 1 reports the features of patients with F-Dys and CD.  At the time of the 
assessment, the two groups were comparable for age of onset (F-Dys=27.3±12.1 years, 
CD=37.5±15.8; p= 0.5), disease duration (p=0.7), level of anxiety (p=0.9) and depression 
(p=0.8). Among F-Dys, 4 patients had an exclusive involvement of facial muscles and the 
movement disorder was paroxysmal in 6 patients. The mean PMDRS score was 23.3+2.8. 
CD patients had isolated cervical dystonia, except for two patients who also presented 
writer's cramp. 
The values of S-Th, P-Th and P-Tol in HC, CD, F-Dys recorded from the right and left 
hand and foot are displayed in table 2. For both S-Th and P-Th, R-ANOVA did not show 
any effect of the factor "group".  No effect of group was found for pain intensity at pain 
threshold level by VAS (hands: F2,35=0.56, p=0.57; feet: F2,35=1.31, p=0.29). An effect of 
the factor "group" was found for P-Tol in both the hands (F2,35=3.766, p=0.033) and the 
feet (F2,35=3.986, p= 0.028). No effect of the factor “side” (hands: F2,35=0.68, p= 0.41; feet: 
F2,35=0.16, p= 0.70) nor an interaction “side*group” (hand: F2,35=1.27, p= 0.29; feet: 
F2,35=0.02, p= 0.99) was found. Post-hoc analysis by unpaired t-test revealed a higher P-
Tol in F-Dys compared to HC and CD, in the upper and lower limbs; no differences of P-
Tol were found between CD and HC.   
Figure 1 shows the individual values for P-Th and P-Tol in the 3 groups of subjects. For P-
Tol, we had to increase the stimulus duration in 3 subjects with F-Dys who reported an 
unbearable stimulation at 0.5 ms (2 subjects for the right hand, right foot, left foot; 1 
subject for the left hand) and 1 second (1 subject for all body districts.). As it was not 
possible to account for stimulus duration in the analysis only for 3 subjects, a value of 100 
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mA (corresponding to the maximal allowed stimulation with 0.2 ms pulse width) was set as 
P-Tol in these subjects.  
To understand if the increased P-Tol was influenced by the temporal course of functional 
dystonic manifestation (persistent or paroxysmal), we conducted a further analysis 
comparing CD patients to F-Dys with persistent (continuous F-Dys) and paroxysmal 
(paroxysmal F-Dys) functional symptoms. There was no main effect of the factor "group" 
both for S-Th in hands (F2,19= 1.41, p = 0.27) and feet (F2,19= 2.11, p = 0.16) and P-Th in 
hands (F2,19= 0.82, p = 0.45) and feet (F2,19= 0.99, p = 0.39). Neither a significant effect of 
“side” or an interaction “side*group” were found for S-Th and P-Th in the hands and feet.  
For P-Tol, we found a “group” effect (F2,19=9.89; p=0.001), but neither an effect of “side” 
(F2,19=1.63; p=0.21) nor an interaction “side*group” (F2,19=0.4; p=0.67). This effect was 
determined by a higher P-Tol in both hands and feet of F-Dys with continuous F-Dys 
compared to paroxysmal F-Dys and CD (Figure 2). Similar results for P-Tol were disclosed 
also in the lower limbs, as revealed by a main effect of “group” (F2,19=4.15; p=0.03) but 
neither an effect of “side” (F2,19=0.06; p=0.81) nor an interaction “side*group” (F2,19=0.01; 
p=0.98) (Figure 2).  
In CD and F-Dys, Spearman Rank Correlation did not show any correlation between P-tol 
in hands and feet with age, disease duration, pain scores of the TWSTRS, BFM, HDRS, 
HARS (Table 3). Only HDRS was correlated to pain severity score of the TWSTRS in F-
Dys. 
DISCUSSION 
Painful sensory modalities have been poorly examined in idiopathic cervical dystonia and 
functional dystonia, two conditions characterized by pain, likely to be underlined by a 
different mechanism. Tactile and pain thresholds were comparable between F-Dys, CD 
and HC, whereas pain tolerance was higher in F-Dys. This increase occured in both the 
upper and lower limbs only in subjects with persistent F-Dys, as paroxysmal F-Dys and 
idiopathic cervical dystonia had comparable pain tolerance.  
Pain is a frequent feature associated to cervical dystonia, occurring in up to 88.9% of 
patients naïve to BoNT and being correlated with severity of dystonic symptoms3. Whether 
pain in cervical dystonia is related to chronic muscular contraction or is generated by an 
alteration of transmission and processing of nociceptive stimuli has been matter of debate 
for a long time8, 18-20. Several sensory modalities have been explored in idiopathic isolated 
dystonia and one of the most frequently reported alteration is the prolonged temporal 
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tactile discrimination threshold, which is a common feature to different types of dystonia, 
regardless the affected body segment 21, 22. Pain is a sensory modality, which is 
transmitted by A-δ and C fibers and can be explored using a variety of stimuli, including 
pain thresholds evoked by thermal sensation and mechanical pressure. Electrical 
stimulation at high intensity as per pain threshold testing can stimulate small diameter, 
high threshold cutaneous afferents (A-delta) and even C-fibers23. When considering 
perception of mechanical painful stimuli, two studies on pain-pressure thresholds were 
conducted in CD with opposite results. An earlier study found reduced pain-pressure 
thresholds in 9 patients with CD (6 of them never treated with BoNT) compared to 5 
healthy subjects19. However, when assessing a larger sample of 39 patients with CD, 
Kutvonen and coworkers found normal pain-pressure thresholds20. The normality of pain 
thresholds and tolerance in our CD sample parallels these early findings, obtained with 
pressure painful stimuli and supports the view that at least cutaneous nociceptive 
pathways are normal in patients with idiopathic CD chronically treated with BoNT. Overall, 
they are in keeping with the evidence that the amplitude of N2/P2 at laser evoked potential 
is comparable between CD and healthy subjects, regardless of stimulating a painful or 
painless area in dystonia8.  
The abnormality of pain tolerance only in patients with persistent dystonic functional 
symptoms supports the recent view that there are distinct phenotypes among F-Dys24. 
However, data on pathophysiological differences among F-Dys phenotypes are not 
available. The increase of pain tolerance together with the normality of pain threshold, 
suggests a dissociation between the sensory-discriminative and cognitive-affective 
components of pain in persistent F-Dys. These two dimensions of pain are regulated by 
separate but parallel neural systems, respectively the lateral pain system (sensory-
discriminative dimension of pain) and the medial pain system (cognitive-affective 
dimension of pain)25. The lateral system projects to the primary somatosensory cortex 
through the lateral thalamic nuclei whereas the medial system projects to several brain 
regions, including the cingulate cortex and limbic system, via the medial medial thalamic 
nuclei. The two systems are functionally segregated and can be separately assessed by 
applying nociceptive stimuli of different intensities26. The dissociation of the two systems in 
F-dys is in keeping with two previous studies, reporting increased pain tolerance and 
normal sensory-discriminative thresholds in patients with multisomatoform disorders27, 28. 
The category “somatoform” refers to DSM-IV TR, which included in this entity somatization 
and conversion disorder, pain, hypochondria and body dysmorphic disorder. Clinical 
Page 24 of 38
John Wiley & Sons
Movement Disorders
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Morgante et al, Pain processing in CD and F-Dys 
 
9 
 
features of subjects in these previous reports were not specified, therefore it is not 
possible to ascertain whether any functional movement disorder and more specifically 
functional dystonia was included. Nevertheless, both these studies reported averaged 
values from the right and the left hand and did not assess lower limbs.  
Two psychological features of patients with FND might explain the increased pain 
tolerance in F-Dys: 1) the higher frequency of alexithymia, which refers to the inability to 
identify one’s own emotions at a cognitive level29; 2) the lower interoceptive awareness, 
which is predictive of their tendency to focus on the external features of their body30. A 
similar reduced interoceptive sensitivity was also found in somatoform patients who 
disclosed increased pressure-pain tolerance27.  
A hypothesis to explain our findings in F-Dys is that the increased pain tolerance might be 
caused by abnormalities in limbic areas involved in emotion and pain processing (anterior 
cingulate cortex) and implicated in assigning emotional salience (amygdala, anterior 
insula, and posterior cingulate cortex). Indeed, abnormalities in areas involved in emotion 
recognition and processing has been shown in patients with FND31-33. Moreover, FND 
subjects have reduced activity and lower connectivity of the right temporoparietal junction 
(an area involved in generating an appropriate sensory prediction signal) with 
sensorimotor and limbic regions, such as the anterior cingulate cortex and right ventral 
striatum32. Noteworthy, deep brain stimulation or lesioning of the anterior cingulate cortex 
are able to decrease the affective response to noxious stimuli and are employed to treat 
major depression or intractable pain34. This hypothesis needs confirmation by further 
studies emplying functional neuroimaging with pain stimuli tasks as well ass assessment 
of emotional processing and alexithymia.  
When interpreting our results, we should also consider recent theories on FND35  
postulating that two important mechanisms for generating these abnormal movements are 
self-focus attention and ‘brain-expectations’. In fact, strong "top down” influences, such 
“prior beliefs” would tend to modify any "bottom up" sensory information. Moreover, 
excessive attention towards the body36 might underlie the decrease in externally directed 
attention. These could influence the cognitive appraisal of pain tolerance. However, this 
mechanism would not entirely explain the dissociation between pain threshold and 
tolerance in F-Dys. 
Finally, chronic functional dystonia might have determined a reorganization of sensory 
areas, as it has been demonstrated in complex pain regional syndrome type I, a condition 
that should be included into the functional symptoms spectrum based on clinical and 
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neurophysiological evidence37. When dealing with pain it is also fundamental to discuss 
the role of emotions and mood on pain processing. Indeed, decreased pain thresholds and 
pain tolerances in Parkinson’s disease were correlated to severity of depressive 
symptoms5 and a similar association was found in patients with major depressive 
disorder17.  Regarding the relationship between anxiety and pain tolerance, the literature 
has been controversial on this topic, with reports of decreased pain tolerance in post-
traumatic stress disorder38 or lack of correlation between anxiety and pain tolerance in 
patients with juvenile fibromyalgia38. Accordingly, we screened our sample for depression 
and anxiety and we could not find any correlation with pain tolerance, which also had an 
inverse pattern in F-Dys compared to subjects with major depression. Yet, we need to 
recognize that we did not employ measures of state anxiety and depression that have 
been found to modulate pain perception.   
We recognize that the small sample size of this exploratory study represents an important 
limitation, given the inter-subject variability of psychophysical data, especially in the lower 
limbs. Even though we could not find any correlation between age and pain tolerance in F-
Dys, CD and HC, the role of age on pain tolerance should be specifically addressed in 
future studies, as it has been done for parameters of somatosensory processing, such as 
tactile temporal discrimination thresholds39, 40. Moreover, objective measures such as pain 
evoked potentials or galvanic skin response should be added to P-Tol assessment in 
future studies investigating pain processing in functional dystonia. Chronic treatment with 
botulinum toxin and oral medication might also have interfered with pain thresholds 
testing, although they were equally distributed between patients’ groups.  
In conclusion, we reported a dissociation between the discriminative and affective 
dimension of pain in patients with persisten F-Dys, documented by a marked increase in 
pain tolerance in all body parts. Our data shed a light on the dissociation between pain 
perception and its emotional processing in patients with functional dystonia, which might 
be used to develop novel rehabilitation protocols, given the profound disability caused by 
pain and its negative impact on the selection for current physiotherapy protocols41.  
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LEGEND TO FIGURES 
Figure 1. Individual values for pain threshold and pain tolerance in functional dystonia (F-
Dys) compared to idiopathic cervical dystonia (CD) and healthy controls (HC). CD = 
cervical dystonia; F-Dys= functional dystonia; HC = healthy controls; PT = pain threshold; 
P-Tol = Pain tolerance. Dotted and dashed lines respectively refer to the mean and 
standard deviation across the 3 groups. 
 
Figure 2. Pain tolerance was significantly increased in the both hands of subjects with 
persistent functional dystonia (F-Dys-C) compared to paroxysmal functional dystonia (F-
Dys-P) and cervical dystonia (CD). Pain tolerance was increased in both feet of F-Dys-C 
compared to CD; the difference between F-Dys-C and F-Dys-P did not reach statistical 
significance when considering P-Tol in both feet.  
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Table 1: Clinical features of patients affected by Functional and Idiopathic Cervical Dystonia  
 
Pt Gender Age (y) 
Disease 
duration (y) 
Affected Body 
District 
BFM- 
Mov 
BFM- 
Dis 
Pain 
score
¶
 
Pain 
Duration
¶
 
Pain 
Disability
¶
 
HARS HDRS 
FUNCTIONAL DYSTONIA 
1 M 42 4 Generalized - Px 0 0 5.25 2 2 25 19 
2 F 51 37 Generalized - CT 0 0 1.75 2 4 7 21 
3 F 38 28 Generalized - CT 0 0 7.25 5 3 18 13 
4 M 43 22 Generalized - CT 0 0 2.75 2 2 18 12 
5 F 58 15 Neck+UL+trunk - Px 12 11 8.5 3 2 45 23 
6 F 25 6 Neck + UL - CT 5 1 3.25 5 2 6 11 
7 M 50 2 Neck + trunk - CT 18 4 2.5 2 2 5 9 
8 M 35 3 Neck - CT 7 4 4 2 1 11 15 
9 F 37 1 Face - Px 0 4 5.25 2 2 8 13 
10 F 23 0.6 Face - Px 1 8 5 4 4 22 21 
11 F 36 9 Face + UL-Tr - Px 16 4 5 2 2 3 5 
12 F 16 0.3 Face + UL-Tr - Px 8 4 6.75 5 2 18 19 
Mean  
± SD 
4 M/8 F 
37.8 ±  
12.2 
10.66 
±12.2 
- 5.6± 6.7 3.3± 3.5 
4.8 
±2.0 
3.0 
±1.3 
2.3 
±0.9 
15.5 
±11.8 
15.1 
±5.5 
IDIOPATHIC CERVICAL DYSTONIA 
1 F 37 3 Neck – UL* 6 4 4 10 5 4 8 
2 M 22 1 Neck 5 1 4 4 3 3 4 
3 F 63 14 Neck 7 0 12 3.5 2 2 11 
4 F 57 4 Neck - UL* 4 0 11 3.25 2 2 7 
5 F 72 9 Neck 9 1 12 6 5 3 13 
6 F 39 15 Neck 4 0 7 4.5 2 2 7 
7 F 66 16 Neck 1.5 0 7 5 1 2 16 
8 M 51 26 Neck 5 2 4 2.5 1 1 17 
9 F 54 16 Neck 0.5 0 6 3.5 5 2 7 
10 M 27 10 Neck 4 0 5 4 3 0 14 
Mean 
± SD 
3 M/7 F 
48.8 
±16.9 
11.4 
7.6 
- 
4.6 
±2.5 
0.8 
±1.3 
7.2 
±3.3 
3.9 
±2.9 
2.6 
±1.6 
2.0 
±1.2 
10.4 
±4.4 
p-value  0.06 0.4 - 0.7 0.06 0.6 0.8 0.7 *0.0001 0.06 
 
BFM-Mov= Burke Fahr Marsden Movement scale; BFM-Dis= Burke Fahr Marsden Disability scale; CT = Continuous; F=female; HARS= Hamilton Anxiety Rating 
Scale; HDRS=Hamilton Depression Rating Scale; M=male; y= years; pt= patient; Px = paroxysmal; SD= Standard Deviation; UL= upper limb; UL-Tr = upper limb 
tremor.  * Writer’s cramp. 
¶ 
Pain sub-scores from the Toronto Western Spasmodic Torticollis Rating Scale (version 1). Comparisons by Mann-Whitney U test. 
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Table 2: Tactile and Pain Thresholds in Functional and Cervical Idiopathic Dystonia and Healthy Controls 
 
  
Body  
site 
Functional 
Dystonia 
Idiopathic 
Dystonia 
Healthy 
controls 
Main Effects, F-value, P-value 
TACTILE 
THRESHOLD 
(mA) 
RH 2.03 ± 0.58 1.573 ± 0.45 1.67 ± 0.41 Group: F2,35 = 2.012; p = 0.1494 
Side: F2,35= 1.614; p = 0.2125 
Group*side: F2,35= 1.953; p = 0.1574 LH 1.93 ± 0.41 1.816 ± 0.37 1.78 ± 0.33 
RF 7.15 ± 4.2 5.862 ± 1.35 5.01 ± 1.05 Group: F2,35 = 2.741; p = 0.0807 
Side: F2,35 = 1.638; p = 0.2105 
Group*side: F2,35= 0.524; p = 0.5977 LF 6.19 ± 1.50 5.397 ± 1.38 4.98 ± 1.49 
PAIN 
THRESHOLD 
(mA) 
RH 20.96 ± 23.64 8.55 ± 5.56 10.53 ± 3.39 Group: F2,35 = 1.171; p = 0.3219 
Side: F2,35 = 1.126; p = 0.2959 
Group*side: F2,35= 2.125; p = 0.1346 LH 17.12 ± 14.63 19.38 ± 8.74 12.31 ± 5.86 
RF 41.97 ± 21.27 31.73 ± 1.60 28.78 ± 11.42 Group: F2,35= 2.084; p = 0.1416 
Side: F2,35 = 1.552; p = 0.2222 
Group*side: F2,35= 1.361; p = 0.2712 LF 41.88 ± 20.31 41.12 ± 6.46 29.12 ± 10.69 
PAIN 
TOLERANCE 
(mA) 
RH 66.8 ± 38.09 36.26 ± 35.22 32.97 ± 23.79 Group: F2,35 = 3.766; p = 0.033 
Side: F2,35 = 0.68, p = 0.41 
Group*side: F2,35 =1.27, p = 0.29 LH 59.88 ± 33.27 34.10 ± 29.04 35.60 ± 28.06 
RF 79.05 ± 25.25 58.97 ± 24.82 60.12 ± 18.53 Group: F2,35=3.986, p = 0.028 
Side: F2,35=0.16, p= 0.70 
Group*side: F2,35=0.02, p= 0.99 LF 80.41 ± 23.74 59.50 ± 31.03 60.70 ± 18.84 
LF= Left Foot; LH= Left Hand; RF= Right Foot; RH= Right Hand 
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Table 3: Correlations between pain tolerance and demographic and clinical data in Functional and Cervical Idiopathic 
Dystonia  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BFM-Mov= Burke Fahr Marsden scale; HARS= Hamilton Anxiety Rating Scale; HDRS=Hamilton Depression Rating Scale; 
¶
Pain sub-scores from 
the Toronto Western Spasmodic Torticollis Rating Scale (version 1). Values are Spearman’s rho; *p<0.05, ** p<0.01 
 Age Disease 
duration 
P-Tol 
hand 
P-Tol 
foot 
Pain 
severity  
Pain 
duration  
Pain 
disability  
BFM  HDRS 
Functional Dystonia 
Disease duration .52         
P-Tol hand .39 .48        
P-Tol foot .18 .23 .78**       
Pain severity¶ -.15 -.23 -.44 -.38      
Pain duration¶  -.47 -.21 -.1 -.05 .48     
Pain disability¶ .11 .09 -.02 .01 -.05 .30    
BFM -.11 -.28 .07 .14 .01 .06 -.40   
HDRS -.08 -.19 -.52 -.10 .63* .30 -.18 -.20  
HARS .18 .02 -.40 -.28 .58 .25 -.30 -.38 .89** 
 Age Disease 
duration 
P-Tol 
hand 
P-Tol 
foot 
Pain 
severity  
Pain 
duration  
Pain 
disability  
BFM  HDRS 
Cervical Dystonia 
Disease duration .35         
P-Tol hand -.25 -.09        
P-Tol foot -.22 -.22 .19       
Pain severity¶ .28 -.16 -.15 -.07      
Pain duration¶    -67 .54 .62     
Pain disability¶   -.04 .57 .73* -.53    
BFM  .15 -.44 -.33 .61 .34 .56 .47   
HDRS .38 -.03 -.45 -.16 .51 .24 -.26 .27  
HARS .36 .55 .06 -.32 .36 -.38 -.46 .12 .51 
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Supplementary Table. Concomitant medication in Functional and Idiopathic Cervical 
Dystonia 
  
 
CT = Continuous; Px = paroxysmal; UL= upper limb; UL-Tr = upper limb tremor.  * Writer’s cramp 
 
Pt Gender Age (y) Affected Body District Medication 
Functional Dystonia 
1 M 42 Generalized - Px 
Botulinum Toxin 
Duloxetine 30 mg/daily 
Clonazepam 2 mg/daily 
2 F 51 Generalized - CT 
Botulinum Toxin 
Escitalopram 10 mg/daily 
Clonazepam 2 mg/daily 
3 F 38 Generalized – CT - 
4 M 43 Generalized – CT - 
5 F 58 Neck+UL+ trunk - Px 
Botulinum Toxin 
Lorazepam 1 mg/daily 
6 F 25 Neck + UL – CT 
Botulinum Toxin 
Clonazepam 1 mg/daily 
7 M 50 Neck + trunk - CT - 
8 M 35 Neck - CT Paroxetine 10 mg/daily 
9 F 37 Face - Px - 
10 F 23 Face - Px - 
11 F 36 Face + UL-Tr - Px Clonazepam 2 mg/daily 
12 F 16 Face + UL-Tr - Px Clonazepam 1 mg/daily 
Idiopathic Cervical Dystonia 
1 F 37 Neck – UL* Botulinum toxin 
2 M 22 Neck 
Botulinum toxin 
Clonazepam 2 mg/daily 
3 F 63 Neck Botulinum toxin 
4 F 57 Neck - UL* 
Botulin toxin  
Clonazepam 3 mg/daily 
5 F 72 Neck Botulinum toxin 
6 F 39 Neck Botulinum toxin 
7 F 66 Neck 
Botulinum toxin 
Lorazepam 1 mg/daily 
8 M 51 Neck 
Botulinum toxin  
Escitalopram 10 mg/daily 
9 F 54 Neck 
Botulinum toxin  
Paroxetine 20 mg/daily 
10 M 27 Neck 
Botulinum toxin  
Clonazepam 2 mg/daily 
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